Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.

  • E T Wong, K R Hess, +5 authors W K Yung
  • Published 1999 in
    Journal of clinical oncology : official journal…


PURPOSE To determine aggregate outcomes and prognostic covariates in patients with recurrent glioma enrolled onto phase II chemotherapy trials. PATIENTS AND METHODS Patients from eight consecutive phase II trials included 225 with recurrent glioblastoma multiforme (GBM) and 150 with recurrent anaplastic astrocytoma (AA). Their median age was 45 years… (More)